BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 10160112)

  • 21. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.
    Anell A; Svarvar P
    Pharmacoeconomics; 2000 Feb; 17(2):175-85. PubMed ID: 10947340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
    Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
    Crane VS
    Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How to improve pharmacoeconomic data generalisability between different countries.
    Li SC
    Expert Opin Pharmacother; 2007 Jul; 8(10):1409-13. PubMed ID: 17661723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between practice guidelines, formulary management, and pharmacoeconomic studies.
    Schrogie JJ; Nash DB
    Top Hosp Pharm Manage; 1994 Jan; 13(4):38-46. PubMed ID: 10130682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of pharmacoeconomic guidelines for formulary approval: the Australian experience.
    Langley PC
    Clin Ther; 1993; 15(6):1154-76; discussion 1120. PubMed ID: 8111812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.
    Al Aqeel SA; Al-Sultan M
    Saudi Pharm J; 2012 Jul; 20(3):187-94. PubMed ID: 23960792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incorporating pharmacoeconomic principles into hospital pharmacy practice.
    Gouveia WA; Bungay KM
    Top Hosp Pharm Manage; 1994 Jan; 13(4):31-7. PubMed ID: 10130681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial treatment strategies in hospitalized patients: what role for pharmacoeconomics?
    Goldman MP; Nair R
    Cleve Clin J Med; 2007 Aug; 74 Suppl 4():S38-47. PubMed ID: 17847177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bleeding edge of decision making in managed health care--Kaiser-Permanente's model for formulary development.
    Campen D
    Value Health; 2002; 5(5):383-9. PubMed ID: 12201855
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacoeconomics].
    Shiragami M
    Yakugaku Zasshi; 2003 Mar; 123(3):133-42. PubMed ID: 12693013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The formulary decision-making process in a health maintenance organisation setting.
    Shepherd MD; Salzman RD
    Pharmacoeconomics; 1994 Jan; 5(1):29-38. PubMed ID: 10146864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the Presence of Cognitive Biases in Health Care Decision Making: A Survey of U.S. Formulary Decision Makers.
    Mezzio DJ; Nguyen VB; Kiselica A; O'Day K
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1173-1183. PubMed ID: 30362919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating observational data into the formulary decision-making process--summary of a roundtable discussion.
    Holtorf AP; Watkins JB; Mullins CD; Brixner D
    J Manag Care Pharm; 2008 Apr; 14(3):302-8. PubMed ID: 18439052
    [No Abstract]   [Full Text] [Related]  

  • 40. A pharmacoeconomics and formulary management collaborative project to teach decision analysis principles.
    Cavanaugh TM; Buring S; Cluxton R
    Am J Pharm Educ; 2012 Aug; 76(6):115. PubMed ID: 22919091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.